How Can Translational Medicine Fill the Gaps in Life Sciences Industries?
Track
:
Track 19: Communities Showcase
Program Code:
123
Date:
Monday, June 24, 2013
Time:
11:00 AM to 12:30 PM
EST
Location:
102AB
CHAIR
:
Aamir Shahzad, MD (SCHSUP), President, European Society For Translational Medicine (EUSTM), Austria
Currently based in Vienna, Austria, Prof. Shahzad serves as President for the European Society for Translational Medicine' and Chair for TM Community at DIA. He also serves as editor-in-chief for the journals Molecular Medicine & Therapeutics and Translational Biomedicine.
SPEAKER
(S):
Michael N Liebman, PhD (SPKNON), Managing Director, IPQ Analytics, United States
Michael N. Liebman, Ph.D. is the Manag. Dir. of IPQ Analytics and Strategic Medicine, Exec Dir of Windber Res Inst 2003-2007, Dir., Comp Bio and Biomed Inform. at U of PA Cancer Ctr 2000-2003 and Global Head of Comp Genomics, Roche and Director, Bioinformatics and PGX, Wyeth and co-founded Prosanos
Nicholas John Sarlis, MD,PhD (SPKNON), Vice President and Head, Medical Affairs, Experimental Station, Incyte Corporation, United States
Dr. Sarlis is VP & Head of Medical Affairs with Incyte Corp., a specialty pharmaceutical company focused on oncology & inflammation in Wilmington, DE. Previously he was Sr Medical Dir with sanofi-aventis & the US liaison to the global franchise for several oncology products.
Anastasia M Christianson, PhD (SPKNON), Senior Director, R&D Information, AstraZeneca, United States
He has 15+ years experience as a consultant to pharma and biotechs throughout the US and Europe where he also advises on organizational design, process innovation and technology enablement.Chip holds a Bachelor of Science in Electrical Engineering from Bucknell University in Lewisburg, PA.
Description
The panel in this forum will highlight examples of how translational medicine has been applied and what it can contribute to the life sciences industry.
This forum has been developed by the Translational Medicine Community.